We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+29.99%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$620M
AUM Growth
+$89.5M
Cap. Flow
-$6.73M
Cap. Flow %
-1.09%
Top 10 Hldgs %
50.06%
Holding
57
New
1
Increased
7
Reduced
4
Closed
6

Top Buys

Rank Stock Value
1
BR icon
Broadridge
BR
+$1.67M
2
IBM icon
IBM
IBM
+$1.67M
3
SN icon
SharkNinja
SN
+$1.66M
4
UL icon
Unilever
UL
+$1.62M
5
AVGO icon
Broadcom
AVGO
+$1.55M

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$4.44M
2
UBER icon
Uber
UBER
+$4.23M
3
AAPL icon
Apple
AAPL
+$2.86M
4
ALC icon
Alcon
ALC
+$2.07M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$982K

Sector Composition

Rank Sector Weight
1 Technology 39.25%
2 Industrials 19.29%
3 Consumer Discretionary 13.16%
4 Healthcare 9.57%
5 Communication Services 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$123B
$373K 0.06%
750
ALC icon
52
Alcon
ALC
$34.3B
-27,525
Closed -$2.07M
CRM icon
53
Salesforce
CRM
$140B
-1,440
Closed -$269K
CRSP icon
54
CRISPR Therapeutics
CRSP
$4.71B
-93,300
Closed -$4.44M
MKC icon
55
McCormick & Company Non-Voting
MKC
$13.9B
-19,470
Closed -$982K
RELX icon
56
RELX
RELX
$58.9B
-10,055
Closed -$333K
UBER icon
57
Uber
UBER
$147B
-58,830
Closed -$4.23M

Similar funds

Chad R. Baker's Q2 2026 Portfolio in Review

As of Q2 2026, Chad R. Baker held 57 positions worth $620M, up 17% from $530M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Chad R. Baker's Q2 2026 filing shows 1 new, 7 increased, 4 reduced and 6 closed positions. Its largest new stake was Broadridge: 11,080 shares worth $1.52M. The largest sale was CRISPR Therapeutics, an estimated $4.44M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 33% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Chad R. Baker's largest Q2 2026 buy was Broadridge: 11,080 shares worth $1.52M.
  • Chad R. Baker added most to IBM in Q2 2026, an estimated $1.67M increase.
  • Chad R. Baker's biggest Q2 2026 reduction was Apple, cutting an estimated $2.86M.
  • Chad R. Baker fully exited CRISPR Therapeutics in Q2 2026, selling an estimated $4.44M.
  • Chad R. Baker's ten largest holdings make up 50% of its $620M portfolio in Q2 2026.
  • Chad R. Baker opened 1 new position and closed 6 in Q2 2026.
  • Chad R. Baker's portfolio value rose 17% quarter-over-quarter to $620M.

Based on Chad R. Baker's 13F filing for Q2 2026, filed 16 Jul 2026.